Ling Yu

Dr. Ling Yu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2020 in Industrial & Engineering Chemistry Research
Verified
Journal Article
Closed access
GLGongyan Liu
Gongyan Liu
JXJun Xiang
Jun Xiang
QXQiongfen Xia
Qiongfen Xia
KLKaijun Li
Kaijun Li
HYHui Yan
Hui Yan
LYLing Yu
Ling Yu

14 November 2018 in Cellulose
Verified
Journal Article
Closed access
PDF file
GLGongyan Liu
Gongyan Liu
JXJun Xiang
Jun Xiang
QXQiongfen Xia
Qiongfen Xia
KLKaijun Li
Kaijun Li
TLTianxiang Lan
Tianxiang Lan
LYLing Yu
Ling Yu

20 June 2013 in Acta Ophthalmologica
Verified
Journal Article
Open access
PDF file
HLHongbin Lv
Hongbin Lv
ALAiling Li
Ailing Li
XZXibo Zhang
Xibo Zhang
MXMei Xu
Mei Xu
YQYu Qiao
Yu Qiao
LYLing Yu
Ling Yu
: To perform a comprehensive evaluation and comparison of tear function in diabetic and non‐diabetic patients. Research related to tear function in diabetic and non‐diabetic patients was gathered using PubMed, EBSCO, OVID. Two reviewers independently conducted the literature search. The quality assessment and the data extraction were performed in accordance with exclusion criteria and cross‐checking. RevMan 5.1.7 software was used for the meta‐analysis. The tear film break‐up time was studied in eight articles with a total of 1449 samples. Through a random‐effects model analysis, the combined weighted mean difference (WMD) was −4.44 [−5.87, −3.01]. The time in diabetic patients was shorter than that in the non‐diabetic group (p < 0.00001). The basal tear secretion test was studied in seven articles with a total of 949 samples. The combined WMD was −3.96 [−5.70, −2.23], and the difference between the diabetic group and control group was statistically significant (p < 0.00001). The total tear secretion test was studied in five articles with a total of 921 samples. The combined WMD was −3.96 [−7.43, −0.50]. The difference between the diabetic and control groups was statistically significant (p = 0.03). The corneal sensitivity was compared in eight studies with a total of 976 samples. Through a random‐effects model analysis, the standardized mean difference (SMD) was −5.14 [−6.99, −3.29]. The corneal sensitivity was lower in diabetic patients than the control group (p < 0.00001). Our study suggests that the tear functions are worse in diabetic patients compared with the control group. Moreover, patients with PDR are more predisposed to impaired tear functions.

1 March 2022 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
LMLi Ma
Li Ma
KLKaijun Li
Kaijun Li
JXJiali Xia
Jiali Xia
CCChaojian Chen
Chaojian Chen
YLYuqi Liu
Yuqi Liu
GLGongyan Liu
Gongyan Liu

9 October 2015 in Human Mutation
Verified
Journal Article
Closed access
PDF file
XZXibo Zhang
Xibo Zhang
GQGang Qin
Gang Qin
GCGuilan Chen
Guilan Chen
TLTao Li
Tao Li
LGLinghan Gao
Linghan Gao
LYLing Yu
Ling Yu
Congenital aniridia is a genetic disorder that manifests as iris hypoplasia and other associated ocular complications. Mutations in the paired box 6 (PAX6) gene are considered the major cause of aniridia. In this study, we identified four mutations exclusively presented in aniridia patients from a four-generation Chinese pedigree, including two single nucleotide substitutions in the 3′UTR of PAX6 (NM_000280.4:c.[*76G>A; *2977C>A]) and two missense mutations in tripartite motif containing 44 (TRIM44, NM_017583.4:c.[191C>A; 463G>A]), which lead to amino acid changes p.S64Y and p.G155R, respectively. Bioinformatic analyses revealed that the two 3′UTR mutations of PAX6 disrupted microRNA binding motifs in the wildtype 3′UTR sequence. Luciferase reporter assay and Western blotting with predicted microRNAs showed that the two 3′UTR mutations could only increase or have no effect on the expression of PAX6. Therefore, they would not be the cause of aniridia that resulted from PAX6 deficiency. Instead, we found that overexpression of TRIM44 significantly reduced the expression of PAX6 in human lens epithelial cells, and the p.G155R mutant exhibited much stronger effect than the wildtype form. We conclude that inhibition of PAX6 expression by mutant TRIM44 is a novel pathogenic mechanism for aniridia.

19 August 2015 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
QHQian Han
Qian Han
YWYuqi Wang
Yuqi Wang
XLXiabin Li
Xiabin Li
RPRibo Peng
Ribo Peng
ALAiling Li
Ailing Li
LYLing Yu
Ling Yu